ECM
IRWD icon

ExodusPoint Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

ExodusPoint Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-494,620
Closed -$727K – 1709
2025
Q1 		$727K Buy
+494,620
New +$1.18M 0.01% 1009
2024
Q1 		– Sell
-335,614
Closed -$3.84M – 1715
2023
Q4 		$3.84M Buy
335,614
+163,664
+95% +$1.62M 0.03% 400
2023
Q3 		$1.66M Buy
171,950
+125,721
+272% +$1.23M 0.02% 741
2023
Q2 		$492K Sell
46,229
-425,794
-90% -$4.58M ﹤0.01% 1364
2023
Q1 		$4.97M Buy
472,023
+219,806
+87% +$2.46M 0.04% 520
2022
Q4 		$3.13M Buy
+252,217
New +$2.86M 0.05% 488
2022
Q3 		– Sell
-57,354
Closed -$661K – 2092
2022
Q2 		$661K Sell
57,354
-676,413
-92% -$7.97M 0.01% 1256
2022
Q1 		$9.23M Sell
733,767
-416,978
-36% -$4.78M 0.12% 216
2021
Q4 		$13.4M Buy
1,150,745
+569,760
+98% +$6.99M 0.14% 134
2021
Q3 		$7.59M Buy
580,985
+188,644
+48% +$2.44M 0.1% 267
2021
Q2 		$5.05M Buy
392,341
+207,245
+112% +$2.37M 0.06% 353
2021
Q1 		$2.07M Sell
185,096
-181,876
-50% -$1.92M 0.03% 560
2020
Q4 		$4.18M Buy
366,972
+56,489
+18% +$618K 0.04% 297
2020
Q3 		$2.79M Buy
+310,483
New +$3.09M 0.06% 296
2020
Q1 		– Sell
-18,258
Closed -$243K – 1350
2019
Q4 		$243K Sell
18,258
-6,639
-27% -$73.2K ﹤0.01% 1251
2019
Q3 		$214K Buy
+24,897
New +$242K 0.01% 1091

Other funds holding IRWD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ExodusPoint Capital Management's IRWD Position: Q2 2025 in Review

ExodusPoint Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2025, closing a stake of 494,620 shares — an estimated $727K sold.

ExodusPoint Capital Management first reported a position in IRWD in Q3 2019 and held it in 16 quarters. The position peaked at $13.4M in Q4 2021. 155 funds tracked by Wall St. Rank hold IRWD as of Q2 2025.

  • ExodusPoint Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 494,620 Ironwood Pharmaceuticals shares in Q2 2025, an estimated $727K.
  • ExodusPoint Capital Management first reported a position in Ironwood Pharmaceuticals in Q3 2019 and held it in 16 quarters.
  • ExodusPoint Capital Management's Ironwood Pharmaceuticals position peaked at $13.4M in Q4 2021.
  • 155 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.